We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $27B
1-Year Est. Return 24.49%
This Fund
S&P 500
This Quarter Est. Return
+8.1%
1 Year Est. Return
+24.49%
3 Year Est. Return
+88.53%
5 Year Est. Return
+114.58%
10 Year Est. Return
+419.26%
AUM
$16M
AUM Growth
+$261K
Cap. Flow
-$992M
Cap. Flow %
-6,188.08%
Top 10 Hldgs %
28.06%
Holding
2,439
New
134
Increased
362
Reduced
1,104
Closed
118

Top Buys

Rank Stock Value
1
VCLT icon
Vanguard Long-Term Corporate Bond ETF
VCLT
+$24.3M
2
IQV icon
IQVIA
IQV
+$16.5M
3
CHTR icon
Charter Communications
CHTR
+$11.6M
4
ALSN icon
Allison Transmission
ALSN
+$9.13M
5
CAT icon
Caterpillar
CAT
+$7.88M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78.4M
2
MSFT icon
Microsoft
MSFT
+$53.7M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$24.3M
4
META icon
Meta Platforms (Facebook)
META
+$23.3M
5
JNJ icon
Johnson & Johnson
JNJ
+$21.9M

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Healthcare 11.86%
3 Financials 11.67%
4 Consumer Discretionary 9.16%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBAY
2276
DELISTED
Cymabay Therapeutics
CBAY
$5 ﹤0.01%
1,150
– –
NH
2277
DELISTED
NantHealth, Inc
NH
$5 ﹤0.01%
147
– –
BABA icon
2278
Alibaba
BABA
$308B
$4 ﹤0.01%
16
– –
CNI icon
2279
Canadian National Railway
CNI
$76.6B
$4 ﹤0.01%
34
+13
+62% +$1.44K
EGBN icon
2280
Eagle Bancorp
EGBN
$845M
$4 ﹤0.01%
+70
New +$3.88K
IMVT icon
2281
Immunovant
IMVT
$8.25B
$4 ﹤0.01%
400
– –
PUK icon
2282
Prudential
PUK
$35.2B
$4 ﹤0.01%
119
-28
-19% -$1.15K
WINA icon
2283
Winmark
WINA
$1.32B
$4 ﹤0.01%
20
– –
JNCE
2284
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4 ﹤0.01%
660
– –
CNCE
2285
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$4 ﹤0.01%
910
– –
NBEV
2286
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$4 ﹤0.01%
2,000
-41,700
-95% -$97.2K
CALA
2287
DELISTED
Calithera Biosciences, Inc
CALA
$4 ﹤0.01%
95
– –
ABEO icon
2288
Abeona Therapeutics
ABEO
$413M
$3 ﹤0.01%
79
– –
ASMB icon
2289
Assembly Biosciences
ASMB
$529M
$3 ﹤0.01%
58
– –
GO icon
2290
Grocery Outlet
GO
$980M
$3 ﹤0.01%
83
– –
INZY
2291
DELISTED
Inozyme Pharma
INZY
$3 ﹤0.01%
+200
New +$3.48K
NVS icon
2292
Novartis
NVS
$297B
$3 ﹤0.01%
34
– –
OTRK
2293
DELISTED
Ontrak
OTRK
$3 ﹤0.01%
1
– –
PSTX
2294
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$3 ﹤0.01%
+300
New +$2.69K
AY
2295
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$3 ﹤0.01%
85
– –
BCEL
2296
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$3 ﹤0.01%
+300
New +$3.07K
GTT
2297
DELISTED
GTT Communications, Inc.
GTT
$3 ﹤0.01%
1,360
– –
LJPC
2298
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3 ﹤0.01%
590
– –
AXDX
2299
DELISTED
Accelerate Diagnostics
AXDX
$2 ﹤0.01%
30
-15
-33% -$1.19K
CBUS icon
2300
Cibus
CBUS
$138M
$2 ﹤0.01%
12
– –
90 91
92
93 94

Similar funds

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return

Nisa Investment Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Nisa Investment Advisors held 2,439 positions worth $16M, up 1.7% from $15.8M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Nisa Investment Advisors withdrew a net $992M in Q2 2021, closing 118 positions and reducing 1,104 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $9.13K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nisa Investment Advisors opened a new position in Allison Transmission worth $8.53K.

  • Nisa Investment Advisors's largest Q2 2021 buy was Allison Transmission: 214,659 shares worth $8.53K.
  • Nisa Investment Advisors added most to Vanguard Long-Term Corporate Bond ETF in Q2 2021, an estimated $24.3M increase.
  • Nisa Investment Advisors's biggest Q2 2021 reduction was Apple, cutting an estimated $78.4M.
  • Nisa Investment Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $9.13K.
  • Nisa Investment Advisors's ten largest holdings make up 28% of its $16M portfolio in Q2 2021.
  • Nisa Investment Advisors opened 134 new positions and closed 118 in Q2 2021.
  • Nisa Investment Advisors's portfolio value rose 1.7% quarter-over-quarter to $16M.

Based on Nisa Investment Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.